• MG-132: Precision Proteasome Inhibition as a Transformati...

  2025-10-01

  Explore how MG-132, a potent cell-permeable proteasome inhibitor peptide aldehyde, empowers translational researchers to dissect the ubiquitin-proteasome system, overcome therapeutic resistance, and probe the intricate connections between apoptosis, ferroptosis, and oxidative stress. This thought-leadership article delivers mechanistic insights, actionable experimental guidance, and a strategic vision for advancing cancer biology and precision medicine.

• VX-765: Uncovering Caspase-1 Inhibition and Mitochondrial...

  2025-09-30

  Explore the advanced scientific underpinnings of VX-765, a potent caspase-1 inhibitor, and its distinct role in modulating inflammatory and mitochondrial cell death pathways. This article provides a uniquely integrative analysis, bridging pyroptosis inhibition with emerging insights from RNA Pol II research.

• Cell Counting Kit-8 (CCK-8): Precision Tools for Ferropto...

  2025-09-29

  Explore the advanced applications of Cell Counting Kit-8 (CCK-8) in unraveling ferroptosis and AKT pathway dynamics in cell models. This in-depth guide details the unique scientific mechanisms of CCK-8, featuring WST-8 chemistry, and its transformative role in sensitive cell viability measurement across cancer and liver disease research.

• Adenosine Triphosphate (ATP): Precision Control in Mitoch...

  2025-09-28

  Discover how Adenosine Triphosphate (ATP) orchestrates precise mitochondrial metabolic regulation through novel post-translational mechanisms. This in-depth analysis highlights ATP’s role as a universal energy carrier and extracellular signaling molecule, offering advanced insights for cellular metabolism research.

• Pioglitazone as a Precision Tool for Dissecting PPARγ-Dri...

  2025-09-27

  Explore how Pioglitazone, a potent PPARγ agonist, enables advanced research into immune-metabolic crosstalk, beta cell protection, and inflammation. This article uniquely highlights mechanistic insights and experimental applications distinct from prior coverage in type 2 diabetes mellitus and neurodegeneration.

• ISRIB (trans-isomer): Unlocking Next-Generation Control o...

  2025-09-26

  Explore how ISRIB (trans-isomer), a leading integrated stress response inhibitor, enables mechanistic dissection of cellular stress adaptation and offers unprecedented insights for liver fibrosis and neurodegenerative disease models. This article delivers a unique, systems-level perspective distinct from existing ISRIB content.

• 3X (DYKDDDDK) Peptide: Next-Generation Epitope Ta

  2025-09-25

  Discover how the 3X (DYKDDDDK) Peptide revolutionizes cotranslational protein modification, enabling advanced affinity purification and immunodetection of FLAG fusion proteins. This in-depth analysis reveals unique insights into ribosome-associated processing and metal-dependent ELISA applications.

• Panobinostat (LBH589): Bridging Epigenetic HDAC Inhibitio...

  2025-09-24

  Explore how Panobinostat (LBH589), a broad-spectrum hydroxamic acid-based histone deacetylase inhibitor, uniquely converges epigenetic modulation with cutting-edge apoptotic pathways. This article highlights new mechanistic insights and advanced applications in cancer and resistance research.

• Filipin III: A Precision Tool for Membrane Cholesterol Vi...

  2025-09-23

  Explore how Filipin III, a cholesterol-binding fluorescent antibiotic, enables high-resolution membrane cholesterol visualization and advances understanding of cholesterol-related disease mechanisms. This article examines Filipin III’s unique biochemical properties and its application in dissecting cholesterol dynamics in metabolic liver disorders.

• An important and well documented pathway involved in

  2025-03-03

  

  An important and well-documented pathway involved in cellular growth and proliferation is the mTOR-mediated synthesis of proteins and lipids [7,13,14]. Although found to be tissue specific or context specific regulation, it has always been observed that either one or both the mTOR complexes regulate

• The synthetic adipoR agonists AdipoRon and are both

  2025-03-03

  

  The synthetic adipoR agonists, AdipoRon (1) and 112254 (2), are both detectable in human plasma [18]. However, with increasing knowledge about their metabolism [19], a method for detection from human urine is conceivable and would be preferred given the easier accessibility and greater frequency of

• br Material and methods br Results br Discussion To develop

  2025-03-03

  

  Material and methods Results Discussion To develop a novel regenerative and/or neuroprotective therapy for optic neuropathy, including glaucoma, numerous studies have tested new candidates favorable to RGC survival and axon regeneration. Among the many candidate drugs, AdoR modulators are o

• An alternative approach to the administration of ADO agonist

  2025-03-03

  

  An alternative approach to the administration of ADO agonists is to amplify the actions of endogenous ADO by inhibiting the ADO-metabolizing enzyme, ADO kinase (AK). Inhibition of AK has the net effect of potentiating the local concentration and the effects of ADO in the extracellular compartment. T

• Synthesis pharmacological evaluation for the binding at

  2025-03-03

  

  Synthesis, pharmacological evaluation for the binding at hA, hA and hA ARs, and efficacy at hA subtype of the synthesized compounds, together with the assessment of their theoretical ADME properties were the guidelines in this preliminary drug discovery investigation. The synthetic pathways which y

• Altogether the situations described above

  2025-03-03

  

  Altogether, the situations described above clearly impede the critical steps of drug discovery and development and the scientific process in general [14]. In conclusion, it is the opinion of these authors that many exciting lines of drug discovery (which includes those devoted to nAChR ligands) have

16298 records 2/1087 page Previous Next 12345 下5页 Last page